Development of a quantitative ELISA for SARS-CoV-2 vaccine candidate, NDV-HXP-S, with CpG 1018® adjuvant

• Glavni autori: Marcus Estrada (Autor), Changcheng Zhu (Autor), Anan Bzami (Autor), Jessica A. White (Autor), Manjari Lal (Autor)
• Format: Knjiga
• Izdano: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

ABSTRACTNDV-HXP-S is a Newcastle disease virus (NDV) vectored vaccine candidate which expresses the S-antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This vaccine candidate is under evaluation in human clinical studies with and without cytosine phosphate guanine (CpG) 1018®...